is victoza a glp-1 drug hydrogels could reduce shots to 3 times year GLP-1 drugs may have a

Liraglutide effects on glycemic control and weight in patients with type 2 diabetes Mellitus: A real-world, observational study and brief narrative review

Improving body weight and diabetes control has been associated with improvement in AF recurrence

Semaglutide injections can help patients better manage hunger and support steady, long-term weight loss when paired with lifestyle guidance and medical oversight

The LEAN trial (Liraglutide Efficacy and Action in NASH) was a landmark study published in The Lancet (2016) demonstrating that liraglutide 1.8 mg daily led to NASH resolution in 39% of patients compared to 9% in the placebo group after 48 weeks

L.FleckP

The share who report ever taking these drugs rises to about four in ten (43%) among adults who have been told by a doctor that they have diabetes, a quarter (26%) of adults who have been told they have heart disease, and one in five (22%) adults who have been told by a doctor that they are overweight or obese in the past five years (some of whom also have diabetes or heart disease)